432 related articles for article (PubMed ID: 24791828)
1. Medical nanoparticles for next generation drug delivery to the lungs.
van Rijt SH; Bein T; Meiners S
Eur Respir J; 2014 Sep; 44(3):765-74. PubMed ID: 24791828
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
3. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
4. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
5. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
6. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle formulations in pulmonary drug delivery.
Bailey MM; Berkland CJ
Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
[TBL] [Abstract][Full Text] [Related]
8. Implications of increased nanoparticle absorption by infant lungs: future prospects.
Garcia-Contreras L; Ibrahim M
Ther Deliv; 2013 Apr; 4(4):417-20. PubMed ID: 23557280
[No Abstract] [Full Text] [Related]
9. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of nanoparticles for the treatment of lung diseases.
Azarmi S; Roa WH; Löbenberg R
Adv Drug Deliv Rev; 2008 May; 60(8):863-75. PubMed ID: 18308418
[TBL] [Abstract][Full Text] [Related]
13. Targeting of injectable drug nanocrystals.
Fuhrmann K; Gauthier MA; Leroux JC
Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
[TBL] [Abstract][Full Text] [Related]
14. Micro- and nanocarrier-mediated lung targeting.
Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects.
A R; Han Z; Wang T; Zhu M; Zhou M; Sun X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1933. PubMed ID: 37857568
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine in pulmonary delivery.
Mansour HM; Rhee YS; Wu X
Int J Nanomedicine; 2009; 4():299-319. PubMed ID: 20054434
[TBL] [Abstract][Full Text] [Related]
17. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
18. Nano-Strategies for Improving the Bioavailability of Inhaled Pharmaceutical Formulations.
Xing Y; Lu P; Xue Z; Liang C; Zhang B; Kebebe D; Liu H; Liu Z
Mini Rev Med Chem; 2020; 20(13):1258-1271. PubMed ID: 32386491
[TBL] [Abstract][Full Text] [Related]
19. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
20. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
Baker JR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
